JAGSONPAL PHARMACEUTICALS
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹58 Cr | ₹70 Cr | ₹30 Cr | ₹35 Cr | ₹27 Cr |
| Adjustment | ₹3.59 Cr | ₹-12 Cr | ₹8.27 Cr | ₹9.63 Cr | ₹-1.40 Cr |
| Changes In working Capital | ₹-2.39 Cr | ₹5.34 Cr | ₹5.54 Cr | ₹9.50 Cr | ₹-11 Cr |
| Cash Flow after changes in Working Capital | ₹59 Cr | ₹63 Cr | ₹44 Cr | ₹54 Cr | ₹14 Cr |
| Cash Flow from Operating Activities | ₹47 Cr | ₹55 Cr | ₹35 Cr | ₹47 Cr | ₹6.91 Cr |
| Cash Flow from Investing Activities | ₹-36 Cr | ₹-45 Cr | ₹-25 Cr | ₹-58 Cr | ₹-26 Cr |
| Cash Flow from Financing Activities | ₹-12 Cr | ₹-12 Cr | ₹-8.91 Cr | ₹-0.46 Cr | ₹-18 Cr |
| Net Cash Inflow / Outflow | ₹-0.99 Cr | ₹-1.73 Cr | ₹1.71 Cr | ₹-11 Cr | ₹-36 Cr |
| Opening Cash & Cash Equivalents | ₹11 Cr | ₹13 Cr | ₹11 Cr | ₹23 Cr | ₹59 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹10 Cr | ₹11 Cr | ₹13 Cr | ₹11 Cr | ₹23 Cr |
Compare Cashflow Statement of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,564.5 Cr | -0.5% | 0.2% | 2.9% | Stock Analytics | |
| No other companies found in this Industry | ||||||
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -0.5% |
0.2% |
2.9% |
| SENSEX | -1% |
-2.9% |
-4.9% |
You may also like the below Video Courses